Industry News
Hunter research labs team with Amersham in new project
The University of Newcastle and the Hunter Medical Research Institute have linked up with international life sciences supply company Amersham BioSciences to establish a sophisticated analytical laboratory for research into personalised medicine. [ + ]
Diabetes researcher Zimmett honoured
Diabetes luminary Prof Paul Zimmet has been honoured by his peers, receiving the Kellion Award for his contribution to the field. [ + ]
pSivida claims success in anti-tumour device study
A nano-structured silicon device containing slow-release radiotherapy has successfully halted tumours in an animal study. [ + ]
Cardia spin-off slated for funds, IPO
Research into a promising new anti-diabetes compound derived from tree bark will receive a major funding boost under a heads of agreement deal brokered in Melbourne this week. [ + ]
Progen raises $9.6m in share placement
Small molecule drug company Progen Industries (ASX:PGL, Nasdaq:PGLAF) has doubled its cash reserves in a share placement aimed to help the Brisbane biotech expand its product pipeline. [ + ]
Starpharma teams with IDT, AGT to test and develop drugs
It has been a week for collaborations at the Melbourne-based polyvalent nanotechnology development company, Starpharma (ASX:SPL). [ + ]
SA researchers to have better access to equipment, expertise
A new South Australian initiative aims to give scientists in that state easier access to expensive research equipment and expertise. [ + ]
Benitec appoints RNAi specialist to head US advisory board
Brisbane gene silencing company Benitec (ASX:BLT) has appointed a specialist in DNA-directed RNA interference to chair its scientific advisory board in the United States. [ + ]
Jacques Miller AC wins Australia's top science prize
Carrying on a strong tradition of world class immunology research in Australia, the A$300,000 Prime Minister's Prize for Science has been awarded to Emeritus Professor Jacques Miller AC of the Walter and Eliza Hall Institute of Medical Research in Melbourne.
[ + ]TGR boss joins Novogen board
Bioactive compound development company Novogen (ASX:NRT) has appointed the chief of biotech TGR BioSsciences to its board of directors. [ + ]
Gribbles enters biotech with genomics coup
Pathology giant Gribbles (ASX:GGL) has announced a new subsidiary dedicated to biotechnology, with its first project being the development of a pre-natal screening test to detect genetic and chromosomal abnormalities. [ + ]
Vic govt tenders for review of biotech plan
The Victorian state government's Department of Innovation, Industry and Regional Development (DIIRD) has put up for tender the review of its Biotechnology Strategic Development Plan. [ + ]
Broaden your audience, analyst tells biotechs
Biotechnology companies need to widen the audiences they pitch their messages to, industry analyst David Blake, of BioShares, told attendees at a BioMelbourne Network breakfast meeting today. [ + ]
Eiffel nets $2.2m Start grant
Melbourne drug re-engineering company Eiffel Technologies Ltd (ASX:EIF) has received a pleasant surprise from the Federal Government: a $2.2 million R&D Start grant. [ + ]
Imugene toasts future after formative year
Despite a decrease in revenues and an increase in net loss to AUD$1.3 million, veterinary biotechnology company Imugene (ASX:IMU) has come a long way in its first year as a biotechnology company, according to chairman Graham Dowland, who said it was a "tremendous formative year." [ + ]